ATE330011T1 - Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung - Google Patents
Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendungInfo
- Publication number
- ATE330011T1 ATE330011T1 AT01988772T AT01988772T ATE330011T1 AT E330011 T1 ATE330011 T1 AT E330011T1 AT 01988772 T AT01988772 T AT 01988772T AT 01988772 T AT01988772 T AT 01988772T AT E330011 T1 ATE330011 T1 AT E330011T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- preferred
- segments
- neural thread
- ntp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/697,590 US7259232B1 (en) | 2000-10-27 | 2000-10-27 | Preferred segments of neural thread protein |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE330011T1 true ATE330011T1 (de) | 2006-07-15 |
Family
ID=24801714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01988772T ATE330011T1 (de) | 2000-10-27 | 2001-10-25 | Bevorzugte segmente des ntp-proteins (neural thread protein) und verfahren zu deren verwendung |
Country Status (15)
Country | Link |
---|---|
US (2) | US7259232B1 (de) |
EP (2) | EP1702985A3 (de) |
JP (1) | JP2005512500A (de) |
KR (1) | KR100843792B1 (de) |
CN (1) | CN1492926A (de) |
AT (1) | ATE330011T1 (de) |
AU (1) | AU2002232392A1 (de) |
BR (1) | BR0114977A (de) |
CA (1) | CA2427070A1 (de) |
CY (1) | CY1105380T1 (de) |
DE (1) | DE60120782T2 (de) |
DK (1) | DK1379650T3 (de) |
ES (1) | ES2266296T3 (de) |
PT (1) | PT1379650E (de) |
WO (1) | WO2002034915A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002302239B2 (en) * | 2000-10-27 | 2006-12-14 | Nymox Corporation | Method of preventing cell death using segments of neural thread proteins |
EP1392347B1 (de) * | 2001-05-16 | 2005-08-03 | Nymox Corporation | Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine |
EP1541166B1 (de) * | 2001-05-16 | 2007-12-19 | Nymox Corporation | Prävention des Zelltodes durch Verwendung von Segmenten der Neurofilamentproteinen |
CA2448348C (en) | 2001-05-25 | 2013-07-16 | Nymox Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
US7544771B2 (en) * | 2005-02-23 | 2009-06-09 | Nymox Corporation | Protein and its use in diagnosing Alzheimer's disease |
US11628202B2 (en) | 2015-07-24 | 2023-04-18 | Nymox Corporation | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia |
US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0068375A3 (de) | 1981-06-22 | 1983-04-13 | G.D. Searle & Co. | Rekombinante DNS Technik zur Herstellung von Relaxin |
SE8300693L (sv) | 1983-02-09 | 1984-08-10 | Sven Lofdahl | Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5084559A (en) | 1987-03-27 | 1992-01-28 | Repligen Corporation | Protein a domain mutants |
US5948634A (en) | 1988-12-21 | 1999-09-07 | The General Hospital Coporation | Neural thread protein gene expression and detection of alzheimer's disease |
JP3309972B2 (ja) | 1988-12-21 | 2002-07-29 | ザ・ジェネラル・ホスピタル・コーポレイション | 神経系疾患または機能障害の検出法 |
DE69532485T2 (de) * | 1994-03-07 | 2004-11-04 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Trehalose-freisetzendes Enzym, dafür kodierende DNA, Herstellung und Verwendung |
GB9422175D0 (en) | 1994-11-03 | 1994-12-21 | Univ Dundee | Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof |
US5958416A (en) | 1994-12-16 | 1999-09-28 | Regents Of The University Of Minnesota | Heat shock protein peptides and methods for modulating autoimmune central nervous system disease |
US6610506B1 (en) * | 1995-12-01 | 2003-08-26 | University Technologies International, Inc. | Transferrin binding proteins of Pasteurella haemolytica and vaccines containing same |
US6013763A (en) | 1996-06-04 | 2000-01-11 | Genentech, Inc. | Peptide variants of protein A |
AU1065099A (en) | 1997-09-30 | 1999-04-23 | Cel-Sci Corporation | Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
WO2000001720A2 (en) | 1998-07-02 | 2000-01-13 | President And Fellows Of Harvard College | Compositions and methods for treating papillomavirus-infected cells |
WO2000055198A1 (en) | 1999-03-12 | 2000-09-21 | Human Genome Sciences, Inc. | 50 human secreted proteins |
EP1165827A4 (de) | 1999-03-26 | 2003-05-02 | Human Genome Sciences Inc | 45 humane sekretierte proteine |
EP1392347B1 (de) | 2001-05-16 | 2005-08-03 | Nymox Corporation | Prävention des zelltodes durch verwendung der segmente der neurofilamentproteine |
-
2000
- 2000-10-27 US US09/697,590 patent/US7259232B1/en not_active Expired - Lifetime
-
2001
- 2001-10-25 CN CNA018212131A patent/CN1492926A/zh active Pending
- 2001-10-25 WO PCT/US2001/042813 patent/WO2002034915A2/en active IP Right Grant
- 2001-10-25 PT PT01988772T patent/PT1379650E/pt unknown
- 2001-10-25 JP JP2002537885A patent/JP2005512500A/ja active Pending
- 2001-10-25 DE DE60120782T patent/DE60120782T2/de not_active Expired - Lifetime
- 2001-10-25 EP EP06115298A patent/EP1702985A3/de not_active Withdrawn
- 2001-10-25 BR BRPI0114977-6A patent/BR0114977A/pt not_active IP Right Cessation
- 2001-10-25 CA CA002427070A patent/CA2427070A1/en not_active Abandoned
- 2001-10-25 AT AT01988772T patent/ATE330011T1/de not_active IP Right Cessation
- 2001-10-25 AU AU2002232392A patent/AU2002232392A1/en not_active Abandoned
- 2001-10-25 ES ES01988772T patent/ES2266296T3/es not_active Expired - Lifetime
- 2001-10-25 EP EP01988772A patent/EP1379650B1/de not_active Expired - Lifetime
- 2001-10-25 KR KR1020037005830A patent/KR100843792B1/ko not_active IP Right Cessation
- 2001-10-25 DK DK01988772T patent/DK1379650T3/da active
-
2006
- 2006-09-12 CY CY20061101300T patent/CY1105380T1/el unknown
-
2007
- 2007-07-23 US US11/878,288 patent/US20090258426A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2266296T3 (es) | 2007-03-01 |
CN1492926A (zh) | 2004-04-28 |
KR100843792B1 (ko) | 2008-07-03 |
WO2002034915A2 (en) | 2002-05-02 |
DK1379650T3 (da) | 2006-10-23 |
AU2002232392A1 (en) | 2002-05-06 |
US20090258426A1 (en) | 2009-10-15 |
JP2005512500A (ja) | 2005-05-12 |
DE60120782D1 (de) | 2006-07-27 |
CY1105380T1 (el) | 2010-04-28 |
US7259232B1 (en) | 2007-08-21 |
CA2427070A1 (en) | 2002-05-02 |
EP1702985A2 (de) | 2006-09-20 |
DE60120782T2 (de) | 2007-05-24 |
EP1379650A2 (de) | 2004-01-14 |
WO2002034915A3 (en) | 2003-11-20 |
KR20030067681A (ko) | 2003-08-14 |
EP1379650B1 (de) | 2006-06-14 |
EP1702985A3 (de) | 2007-03-07 |
BR0114977A (pt) | 2006-05-09 |
PT1379650E (pt) | 2006-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE516304T1 (de) | Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden | |
CY1105380T1 (el) | Προτιμωμενα τμηματα της νευρικης νηματικης πρωτεϊνης και μεθοδοι χρησης αυτων | |
DE60044058D1 (de) | Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung | |
DE60026452D1 (de) | Verfahren zur Identifizierung von Peptidensequenzen und Proteinensequenzen mittels Massenspektromterie | |
DE69937419D1 (de) | Neisseria Meningitidis Antigene und Zusammenstellungen | |
DE69631504D1 (de) | Verfahren zur Verbesserung des Signal-Rausch-Verhältnisses von Abtastern von fluoreszierenden Strichcoden und Markierungen | |
DE69710077D1 (de) | Verfahren zur erkennung von verbindungen, die die interaktion von rna und rna-bindeproteinen beeinflussen | |
DE60320362D1 (de) | Verfahren zur Herstellung von Dipeptiden | |
FI962247A (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät | |
DE69633563D1 (de) | Neues verfahren zur gewinnung und reinigung von fusionsproteinen | |
ATE164065T1 (de) | Neues verfahren zur behandlung von depression | |
DE69831500T2 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
ATE290315T1 (de) | Von humanem hitzeschockprotein 60 hergeleitete peptide zur behandlung von diabetis, entsprechende zusammensetzungen, verfahren und kits | |
DE69502313T2 (de) | Verfahren zur biologischen Reinigung von Gasströmen | |
DE3873087T2 (de) | Verfahren zur desodorierung und reinigung von agressiven, uebelriechenden gasen. | |
DK0845034T3 (da) | Peptid med pronociceptive egenskaber | |
ATE190630T1 (de) | Angiotensin-ii typ-1 rezeptor und dessen herstellung | |
DE60029327D1 (de) | Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe | |
ATE312914T1 (de) | Rdgb-proteine | |
ATE387460T1 (de) | Verfahren und kit zur beurteilung des ausbruchs von rheumatoider arthritis | |
ATA110696A (de) | Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein | |
HUP0203080A2 (hu) | A PRV-1 gén és felhasználása | |
DE60139458D1 (de) | Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide | |
DE60222240D1 (de) | Verfahren zur isolierung von extrachromosomaler dna und zur verwendung dieser dna zur erkennung von krankheiten | |
DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1379650 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |